Autophagy protects podocytes from sublytic complement induced injury

Area of Science:

• Nephrology
• Cell Biology
• Immunology

Background:

• Membranous nephropathy (MN) is characterized by podocyte injury from sublytic complement attack.
• Understanding the role of cellular processes like autophagy in podocyte injury is crucial for developing therapeutic strategies.

Purpose of the Study:

• To investigate the role of autophagy in podocyte injury induced by sublytic complement attack in vitro.
• To determine whether modulating autophagy affects podocyte survival and injury markers.

Main Methods:

• MPC5 podocytes were subjected to sublytic complement attack in vitro.
• Autophagy was modulated using 3-methyladenine (3-MA) to inhibit and rapamycin to promote it.
• Podocyte injury was assessed by evaluating morphology, stress fibers, apoptosis, survival, and adhesion.

Main Results:

• Sublytic complement attack enhanced autophagy in MPC5 podocytes.
• Inhibition of autophagy with 3-MA exacerbated podocyte injury, increasing apoptosis and decreasing survival/adhesion.
• Promotion of autophagy with rapamycin mitigated injury, reducing apoptosis and improving survival/adhesion.

Conclusions:

• Autophagy plays a protective role against sublytic complement attack-induced podocyte injury in vitro.
• Targeting autophagy could be a potential therapeutic approach for managing membranous nephropathy.